Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-21-011905
Filing Date
2021-06-09
Accepted
2021-06-09 21:38:03
Documents
2
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162328906406532.html 3  
1 FORM 3 wf-form3_162328906406532.xml 3 8139
2 MATTHEW POSARD POA ex-24.htm EX-24 2163
  Complete submission text file 0001628280-21-011905.txt   11757
Mailing Address 11099 N. TORREY PINES ROAD SUITE 100 LA JOLLA CA 92037
Business Address
Posard Matthew L. (Reporting) CIK: 0001543792 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39434 | Film No.: 211006705

Mailing Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109
Business Address 425 PONTIUS AVE N, STE 202 SEATTLE WA 98109 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks